Plunkett Research Online: Intercept Pharmaceuticals Inc

INTERCEPT PHARMACEUTICALS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being develo.....


INTERCEPT PHARMACEUTICALS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 646 747-1000
Fax: 646 747-1001
Address:
New York, NY 10013 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Alfasigma SpA

Contacts Description

Jerome DursoCEO/Director/President
Rocco VeneziaCFO/Chief Accounting Officer/Treasurer
See More
Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. OCA was approved as Ocaliva to treat primary biliary cirrhosis in 2016 and is being develo.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture